It was shown that IL-6 activated gp130 leading to activation of the JAK/STAT pathway (Rose-John, 2018) and the IL-6/JAK/STAT3 pathway is aberrantly hyperactivated in many types of cancer (Johnson et al., 2018). This evidence concerns the gene IL6 and cancer.